IL-27: a double agent in the IL-6 family.

Area of Science:

• Immunology
• Molecular Biology
• Autoimmune Diseases

Background:

• Interleukin-6 (IL-6) is a key therapeutic target for inflammatory and autoimmune conditions.
• Interleukin-27 (IL-27), an IL-6 family member, increasingly shows effects on cellular functions and immunity.
• Both cytokines influence innate and adaptive immunity, often with IL-27 opposing IL-6 actions.

Purpose of the Study:

• To review the roles of IL-6 and IL-27 in inflammation.
• To focus on the involvement of these cytokines in inflammatory arthritis.
• To discuss their significance in diagnosing, stratifying, and treating autoimmune diseases.

Main Methods:

• Literature review of studies on IL-6 and IL-27.
• Analysis of cytokine roles in cellular proliferation, differentiation, and effector functions.
• Examination of their impact on T cell and B cell responses.

Main Results:

• IL-6 and IL-27 modulate myeloid and stromal cell responses, bridging innate and adaptive immunity.
• IL-27 frequently exhibits antagonistic effects compared to IL-6.
• Both cytokines are critical in the context of inflammatory arthritis and broader autoimmune disease pathogenesis.

Conclusions:

• IL-6 and IL-27 are pivotal cytokines in immune responses and inflammation.
• Their distinct and opposing roles are significant for understanding and managing autoimmune diseases.
• Further research into IL-6 and IL-27 pathways may lead to improved diagnostic and therapeutic strategies for inflammatory arthritis and other autoimmune conditions.